Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKQAN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,676
Award facts
- Contract value 100% obligated
- $28,676.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,676.22 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on September 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be completed by September 26, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order represents a child contract under AmerisourceBergen's $999,999,999.00 prime IDC (SPE2DX) with DLA, which runs through December 2026 and provides comprehensive pharmaceutical support globally for military healthcare programs. Dupixent is a specialty immunological medication used to treat conditions including atopic dermatitis, eosinophilic esophagitis, and severe asthma, making this procurement consistent with AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals supplied to the Defense Health Agency and other military healthcare systems. The competitive award demonstrates the contractor's continued capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FKQAN?
SPE2DB25FKQAN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FKQAN worth?
The government has obligated $28,676 on SPE2DB25FKQAN.
Is contract SPE2DB25FKQAN an order under another contract?
Yes. SPE2DB25FKQAN is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKQAN competed?
The extent of competition for SPE2DB25FKQAN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award